Stocksigma LogoStocksigma Logo

Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion

Neochem Bio Solutions reported a 50% YoY increase in revenue from operations to INR 68.9 crore for H1 FY27, with EBITDA rising 25% YoY to INR 12.4 crore

Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion

Neochem Bio Solutions Ltd 路 Investor Presentation 路 29 Oct 2026, 5:52 pm

Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion Neochem Bio Solutions reported a 50% YoY increase in revenue from operations to INR 68.9 crore for H1 FY27, with EBITDA rising 25% YoY to INR 12.4 crore (18.0% margin) and PAT growing 43% YoY to INR 7.8 crore (11.3% margin). Capacity utilization reached 61.8% at its 22,000 MTPA facility. Cash conversion cycle improved to 212 days from 246 days in FY26, while net debt-to-equity stood at 0.38x. Non-textile diversification advanced, with Home & Personal Care revenue expanding 35% YoY to INR 9.8 crore.

Original exchange filing (PDF)

More announcements from Neochem Bio Solutions Ltd

All Neochem Bio Solutions Ltd announcements